10:45am ET
Health and Healthcare
Ebola Stock Fallout Severe on Monday
Some of the Ebola high-flying stocks saw their share prices crater on Monday as Ebola fears are subsiding for several reasons.
Companies
/Healthcare
Biocryst Pharmaceuticals Inc
$9.70
▼ $0.12 (−1.22%) today
Markets closed · 11:48pm ET
BCRX Coverage
Page 412:20pm ET
Health and Healthcare
Ebola Drug Stocks React Wildly to Dallas Patient Death
The sad news that Ebola patient Thomas Eric Duncan has died in a Dallas hospital now raises fears that Ebola drugs might not be a cure-all for patients.
2:05pm ET
Health and Healthcare
Reality Sets in for Ebola Drug Hopefuls
Tekmira Pharmaceuticals downgrade also drags down Sarepta Therapeutics and BioCryst Pharmaceuticals.
9:55am ET
Health and Healthcare
Major Fallout Stocks After Confirmed Ebola Case in United States
With the CDC not releasing enough data on the patient, there could be an opportunity for traders on both sides of the Ebola story.
5:16pm ET
Health and Healthcare
Reaction to Confirmed Ebola Case in U.S. — UPDATED
News has hit of the first confirmed Ebola case in the United States. Companies involved in potential drugs for Ebola have seen their shares pop.
9:34am ET
Health and Healthcare
New Analyst Biotech Stocks to Buy With Gigantic Implied Upside
ThinkstockAfter being absolutely rocked back in the spring, the biotech sector has bounced back smartly. Even a bubble comment from the head of the Federal Reserve Janet Yellen didn’t stop the return of…
8:34am ET
Investing
Top Analyst Upgrades and Downgrades: Zynga, Barrick, Allergan, BioCryst, Mylan, NVIDIA and More
Jon OggStocks turned green on Friday morning on hopes out of Russia, but the markets have remained at risk. Now that investors have an opportunity to look for stocks that have pulled…
11:40am ET
Health and Healthcare
Should Investors Really Be Chasing Potential Ebola Treatments?
ThinkstockThe world is dealing with Ebola outbreaks and scares again. We are also in the midst of debates as to whether two Americans who contracted Ebola in Africa should have been brought back…
Jon C. Ogg 8:45am ET
Investing
Top Analyst Upgrades and Downgrades: AMD, Dish Network, Facebook, Nordstrom, SunPower and More
These are the top Wall Street analyst upgrades, downgrades and initiations for Monday, June 23, 2014. They include AMD, Dish Network, Facebook, Nordstrom and SunPower.
8:20am ET
Health and Healthcare
After Idenix: The Next Four Biotech Buyout Candidates
Here are the four top biotech names we found that all have hepatitis C drugs in their current pipelines at one stage or another and that could be the next takeover targets.
10:50am ET
Health and Healthcare
BioCryst Crushes It on Rare Immune Disorder Drug Trial
BioCryst Pharmaceuticals broke higher Tuesday morning, following the company's announcement that its oral drug for hereditary angioedema met objectives established for its Phase 2a clinical trial.
Paul Ausick 8:25am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, BioCryst, Dow Chemical, Sanmina, Sally Beauty and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, January 28, 2014. They include Apple, Dow Chemical and Sally Beauty.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Cisco, Lululemon, Nokia, Peabody, Xerox and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Monday, January 27, 2014. They include Cisco Systems, Lululemon Athletica, Nokia, Peabody Energy and Xerox.
8:30am ET
Investing
Top Analyst Upgrades and Downgrades: Twitter, Atmel, Gogo, Hologic, Vodafone and More
Jon OggEarnings season may be winding down and the stock market may be close to all-time highs, but now traders and investors alike have to be considering how to position their portfolios…
11:40am ET
Health and Healthcare
Analyst Sees Big Risks Lurking in Possible Biotech Buyout
ThinkstockViroPharma Inc. (NASDAQ: VPHM) has become the latest and greatest biotech buyout candidate after a report of it being a buyout candidate surfaced last week. We saw some 11 million shares trade…